Chitosan Malate Inhibits Growth and Exotoxin Production of Toxic Shock Syndrome-Inducing Staphylococcus aureus Strains and Group A Streptococci
- 1 September 2007
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (9), 3056-3062
- https://doi.org/10.1128/aac.01295-06
Abstract
Previously, it has been shown that the polysaccharide chitosan inhibits the growth of gram-positive bacteria. In this study, chitosan malate was evaluated in broth and thin-film cultures for its effect on the growth and exotoxin production of toxic shock syndrome (TSS)-inducing Staphylococcus aureus (five strains, three producing TSS toxin 1 and one each producing enterotoxin B or C) and group A streptococci (three strains producing streptococcal pyrogenic exotoxin A). Also, the compound was evaluated in a rabbit subcutaneous Wiffle ball model for its ability to prevent S. aureus and group A streptococcal induction of TSS. Finally, chitosan malate was evaluated for its ability to prevent TSS and necrotizing fasciitis in rabbits after subcutaneous inoculation with microbes. Chitosan malate inhibited both bacterial growth and, at sub-growth-inhibitory concentrations, the production of exotoxins, in both broth and thin-film cultures. Rabbits treated with chitosan malate in implanted Wiffle balls were protected from prior challenge with TSS-inducing S. aureus compared to animals not receiving chitosan malate ( P < 0.001) and group A streptococci ( P < 0.005). Chitosan malate protected rabbits from the development of streptococcal TSS with necrotizing fasciitis ( P < 0.01). The data suggest that use of this growth- and toxin-inhibitory compound may be able to reduce the severity of S. aureus and group A streptococcal mucous membrane and trauma-associated skin infections.Keywords
This publication has 42 references indexed in Scilit:
- Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in miceBiomaterials, 2006
- Cost‐effective faster wound healing with a sustained silver‐releasing foam dressing in delayed healing leg ulcers – a health‐economic analysisInternational Wound Journal, 2005
- Methicillin-ResistantStaphylococcus aureusDisease in Three CommunitiesNew England Journal of Medicine, 2005
- Necrotizing Fasciitis Caused by Community-Associated Methicillin-ResistantStaphylococcus aureusin Los AngelesNew England Journal of Medicine, 2005
- Glycerol Monolaurate Inhibits Virulence Factor Production in Bacillus anthracisAntimicrobial Agents and Chemotherapy, 2005
- A Clone of Methicillin-ResistantStaphylococcus aureusamong Professional Football PlayersNew England Journal of Medicine, 2005
- Toxic shock syndrome in a scald burn child treated with an occlusive wound dressingBurns, 2004
- Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin ANew England Journal of Medicine, 1989
- Occlusive wound dressings to prevent bacterial invasion and wound infectionJournal of the American Academy of Dermatology, 1985
- Production of Staphylococcal Pyrogenic Exotoxin Type C: Influence of Physical and Chemical FactorsThe Journal of Infectious Diseases, 1983